Your browser doesn't support javascript.
loading
Impact of different categories of intermediate risk factors on the recurrence of papillary thyroid carcinoma: a retrospective cohort study.
Chen, Qiang; Zou, Xiuhe; Liu, Feng; Su, Anping; Jiang, Yong; Wei, Tao; Gong, Rixiang; Zhu, Jingqiang; Li, Zhihui.
Afiliación
  • Chen Q; Department of Thyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Zou X; Department of Thyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Liu F; Department of Thyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Su A; Department of Thyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Jiang Y; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
  • Wei T; Department of Thyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Gong R; Department of Thyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Zhu J; Department of Thyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Li Z; Department of Thyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.
Int J Surg ; 2024 Jul 08.
Article en En | MEDLINE | ID: mdl-38976907
ABSTRACT

BACKGROUND:

Data regarding the long-term recurrence in patients with intermediate-risk papillary thyroid carcinoma (PTC) are limited. The aim of this study was to assess the impact of primary tumor-related risk factors and lymph node (LN)-only risk factors on recurrence-free survival (RFS) in patients with intermediate-risk PTC. MATERIALS AND

METHODS:

Patients with PTC who received initial treatment at our institution between 2010 and 2016 were retrospectively reviewed. A total of 799 intermediate-risk PTC patients were included and further categorized into subgroups according to the different categories of intermediate risk factors. The RFS rates of these subgroups were investigated and compared.

RESULTS:

Structural recurrence developed in 11 patients (1.4%) of the whole cohort during a median follow-up duration of 96 months. There were no significant differences in RFS between the primary tumor-only risk group and the LN-only risk group, while the combined group of primary tumor risk factors and LN risk factor (metastatic LNs >5) was associated with a worse RFS rate. In the matched-pair analysis, no significant difference in RFS was found between patients who underwent thyroid lobectomy (TL) and those who underwent total thyroidectomy (TT) (6-year RFS 99.6% vs. 98.8%, P = 0.316) during a median follow-up duration of 100 months.

CONCLUSIONS:

Intermediate-risk PTC patients who underwent TL had a comparable RFS to those who underwent TT. The combination of primary tumor risk factors and LN risk factor (metastatic LNs >5) may be a useful tool for predicting the risk of long-term structural recurrence in patients with intermediate-risk PTC.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Int J Surg Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Int J Surg Año: 2024 Tipo del documento: Article País de afiliación: China